drugset / Trial / NCT01079351

A Study of the Pharmacokinetics (PK) and Safety of IV Carbamazepine Relative to Oral Carbamazepine in Adults With Epilepsy

NCT01079351

Phase 1 Completed 98 enrolled Lundbeck LLC
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the safety, tolerability and steady-state pharmacokinetics of intravenous (IV) Carbamazepine (CBZ) infusions relative to orally administered CBZ in adult patients with epilepsy.

Timeline

Start
2007-04
Primary completion
2009-03
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbamazepine Small molecule Intravenous

Indications